Search

everythinglearnresearchcommunity

for

Search:↓

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Activating PKCα in skin causes cell death and inflammation through different pathways.

Type II keratins are uniquely phosphorylated during stress and mitosis, affecting their structure and function.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Androgen receptors help prostate cancer cells grow and resist drugs.

CPK1 helps root hair growth in Arabidopsis by activating channels for calcium signaling.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Artemis phosphorylation at Ser516 may help regulate skin and hair structures.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Akt2 protein is essential for normal cell division in early mouse embryos.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Lower SMAD2/3 activation predicts more severe skin cancer.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Increased Stat3 activity reduces hair follicle stem cells and boosts other stem/progenitor cells.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

VEGFR-2 is active in hair follicles, sebaceous glands, sweat glands, and skin on the human scalp.

There are two ways to start hair growth: one needs Stat3 and the other does not, but both need PI3K activation.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.